Alexion Pharmaceuticals
Bruno Calo currently serves as CFO Germany at Alexion Pharmaceuticals, Inc., since June 2023. Prior to this role, extensive experience was gained at AstraZeneca from June 2014 to June 2023, including positions as CFO & Head of Supply Chain for Portugal, CFO for Portugal, and Global Finance Director for Respiratory & Immunology. Significant contributions include leading finance teams, providing strategic insights, and receiving the AZ 2020 Annual CEO Award for the Portugal Sustainability Strategy. Earlier roles span various finance capacities within AstraZeneca, MedImmune, and Genentech, alongside a solid educational background featuring multiple master's degrees and a PhD in Chemical Engineering.
This person is not in any teams
This person is not in any offices
Alexion Pharmaceuticals
45 followers
Alexion Pharmaceuticals, Inc. is a biopharmaceutical company, which is engaged in the discovery, development and commercialization of biologic therapeutic products aimed at treating patients with severe and life-threatening disease states, including hematologic, kidney and neurologic diseases, transplant rejection, cancer and autoimmune disorders.